HITTING the diagnosis: Testing for heparin-induced thrombocytopenia in cancer patients Journal Article


Authors: Fenelus, M.; Peerschke, E. I. B.
Article Title: HITTING the diagnosis: Testing for heparin-induced thrombocytopenia in cancer patients
Abstract: Objectives To evaluate the use of a pretest probability score (4Ts score) in cancer patients to guide ordering of laboratory screening tests for heparin-induced thrombocytopenia (HIT). Methods A retrospective chart review was conducted for patients (n = 140) in whom laboratory testing for HIT was requested. 4Ts scores were calculated and correlated with heparin-endogenous platelet factor 4 antibody enzyme-linked immunosorbent assay (ELISA) test results. Results All patients with a high pretest probability of HIT (4Ts score = 6-7) had positive ELISA results, compared to 26.1% of patients with intermediate (4Ts score = 4-5) and 4.3% of patients with low (4Ts score ≤3) pretest probability. No patients with 4Ts scores of 2 or less had positive ELISA results. Conclusions HIT can be ruled out in cancer patients (negative predictive value and sensitivity = 100%) with low pretest probability, defined by 4Ts scores of 2 or less, significantly reducing the need for laboratory testing in this patient population. © American Society for Clinical Pathology, 2018. All rights reserved.
Keywords: thrombosis; cost savings; coagulation; hematology; heparin-induced thrombocytopenia; cancer; 4ts score; hit gti-pf4 elisa; laboratory screening; management/administration
Journal Title: American Journal of Clinical Pathology
Volume: 150
Issue: 2
ISSN: 0002-9173
Publisher: Oxford University Press  
Date Published: 2018-08-01
Start Page: 116
End Page: 120
Language: English
DOI: 10.1093/ajcp/aqy040
PROVIDER: scopus
PMCID: PMC6049042
PUBMED: 29901688
DOI/URL:
Notes: Article -- Export Date: 4 September 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maly Fenelus
    13 Fenelus